Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Biophore India Pharmaceuticals Pvt Ltd

02 1Aspen Pharmacare Holdings

03 6ATNAHS PHARMA UK LIMITED

04 2Clinect

05 3ORIFARM GROUP AS

06 4Paranova Group AS

07 1Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Regulatory Info :

Registration Country : India

Olsalazine

Brand Name :

Dosage Form : Capsule

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Biophore

02

arrow
2024 ACI Convention
Not Confirmed

Olsalazine

Brand Name : Dipentum 250

Dosage Form : CAP

Dosage Strength : 250mg

Packaging : 100X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : HARD CAPSULES

Dosage Strength : 250 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Olsalazine

Brand Name : Dipentum

Dosage Form : Capsule, hard

Dosage Strength : 250 mg

Packaging : Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Olsalazine

Brand Name : Dipentum

Dosage Form : Antic-calc Tablet

Dosage Strength : 500 mg

Packaging : Box of plastic

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Olsalazine

Brand Name : Dipentum

Dosage Form : Antic-calc Tablet

Dosage Strength : 500 mg

Packaging : Box of plastic

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OLSALAZINE SODIUM

Brand Name : DIPENTUM

Dosage Form : CAPSULE

Dosage Strength : 250MG

Packaging : 100

Approval Date :

Application Number : 2063808

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazine

Brand Name : Dipentum

Dosage Form : capsule

Dosage Strength : 250 mg

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazine

Brand Name : Dipentum

Dosage Form : tablet

Dosage Strength : 500 mg

Packaging : 100

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : HARD CAPSULES

Dosage Strength : 250 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

olsalazinnatrium

Brand Name : Dipentum

Dosage Form : TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

OLSALAZINE SODIUM

Brand Name : DIPENTUM

Dosage Form : CAPSULE;ORAL

Dosage Strength : 250MG

Packaging :

Approval Date : 1990-07-31

Application Number : 19715

Regulatory Info : RX

Registration Country : USA

blank